US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Mid-America Apartment Communities

162.32

-2.1700-1.32%

Post-market: 162.320.00000.00%16:37 EDT

Volume:626.60K

Turnover:101.93M

Market Cap:18.98B

PE:36.19

High:165.20

Open:164.44

Low:161.56

Close:164.49

Loading ...

Overview Company News Filings

Mid-America Apartment Communities (NYSE:MAA) Declares US$1 Dividend For Series I Preferred Stock

Simply Wall St.

Mid-America Apartment Communities Inc. Stock Outperforms Competitors On Strong Trading Day

Press Release: MAA Announces Regular Quarterly Preferred Dividend

Acadia Pharmaceuticals and Saniona Announce Initial Positive Results from ACP-711 (formerly SAN711) Phase 1 Study

Ocugen Announces Positive Opinion of EMA’s Committee for Advanced Therapies for ATMP Classification for Novel Modifier Gene Therapy Candidate OCU410 for Geographic Atrophy and OCU410ST for Stargardt Disease

Acurx Announces Publication of Nonclinical In Vivo Data Differentiating Ibezapolstat's Gut Microbiome Effects from Other Anti-CDI Antibiotics

Mid-America Apartment Highlights Growth at Citi Conference

MAA to Participate in the 2025 Citi Global Property CEO Conference

Bavarian Nordic Receives Marketing Authorization in Europe for Chikungunya Vaccine for Persons Aged 12 and Older

Acurx Pharmaceuticals to Discuss Fourth Quarter and Full Year 2024 Financial Results on March 18, 2025 Conference Call and Provide Business Update

Mid-America Apartment Communities Inc. Stock Outperforms Competitors On Strong Trading Day

89bio Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates

Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Fourth Quarter and Full Year 2024

Cytokinetics Reports Fourth Quarter 2024 Financial Results and Provides Business Update

Analysts Have Conflicting Sentiments on These Real Estate Companies: Mid-America Apartment (MAA) and Outfront Media (OUT)

Viridian Therapeutics Highlights Recent Progress and Reports Fourth Quarter and Full Year 2024 Financial Results

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.tigerhkgo.com/stock/MAA/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MAA"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MAA\",,,,,undefined,":{"symbol":"MAA","market":"US","secType":"STK","nameCN":"Mid-America Apartment Communities","latestPrice":162.32,"timestamp":1742328000000,"preClose":164.49,"halted":0,"volume":626600,"hourTrading":{"tag":"盘后","latestPrice":162.32,"preClose":162.32,"latestTime":"16:37 EDT","volume":33655,"amount":5462879.2634499995,"timestamp":1742330235499},"delay":0,"changeRate":-0.013192,"change":-2.17,"floatShares":115887070,"shares":116901778,"eps":4.485339,"lyrEps":4.485339,"pbRate":3.19,"amount":101933771.628,"amplitude":0.022099,"volumeRatio":0.668223,"dividePrice":5.88,"prevYearClose":154.57,"fiveDayClose":165,"twentyDayClose":157.56,"impliedVol":0.3577,"impliedVolPercentile":0.984},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MAA\",,,,,undefined,":{"symbol":"MAA","floatShares":115887070,"roa":"3.52%","roe":"8.73%","lyrEps":4.485339,"volumeRatio":0.668223,"shares":116901778,"dividePrice":5.88,"high":165.195,"amplitude":0.022099,"preClose":164.49,"low":161.56,"week52Low":123.73,"pbRate":"3.19","psRate":"8.66","week52High":173.376,"institutionHeld":0.8772,"latestPrice":162.32,"eps":4.485339,"divideRate":0.036225,"volume":626600,"delay":0,"ttmEps":4.485339,"open":164.44,"prevYearClose":154.57,"prevWeekClose":163.31,"prevMonthClose":168.12,"prevQuarterClose":154.57,"fiveDayClose":165,"twentyDayClose":157.56,"sixtyDayClose":156.07},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MAA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-05","symbol":"MAA","fiscalQuarterEnding":"2024/12","expectedEps":2.24,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1738731600000,"reportTimeType":"post","actualEps":2.23},{"date":"2025-01-15","symbol":"MAA","amount":1.515,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-01-15","defaultRemindTime":1736951400000,"name":"MAA房产信托","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-01-31","payableDate":"2025-01-15","currency":"USD","dateTimestamp":1736917200000,"payDate":"2025-01-31"},{"date":"2024-10-30","symbol":"MAA","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2024/09","expectedEps":2.18,"defaultRemindTime":1730318400000,"name":null,"time":"Post Market","dateTimestamp":1730260800000,"actualEps":null},{"date":"2024-10-15","symbol":"MAA","amount":1.47,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-10-15","defaultRemindTime":1728999000000,"name":"MAA房产信托","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-10-31","payableDate":"2024-10-15","currency":"USD","dateTimestamp":1728964800000,"payDate":"2024-10-31"},{"date":"2024-07-31","symbol":"MAA","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2024/06","expectedEps":2.2,"defaultRemindTime":1722456000000,"name":null,"time":"Post Market","dateTimestamp":1722398400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MAA\",market:\"US\",,,undefined,":[{"executeDate":"2015-04-13","recordDate":"2015-04-15","paymentDate":"2015-04-30","value":0.77,"currency":"USD"},{"executeDate":"2015-07-13","recordDate":"2015-07-15","paymentDate":"2015-07-31","value":0.77,"currency":"USD"},{"executeDate":"2015-10-13","recordDate":"2015-10-15","paymentDate":"2015-10-30","value":0.77,"currency":"USD"},{"executeDate":"2016-01-13","recordDate":"2016-01-15","paymentDate":"2016-01-29","value":0.82,"currency":"USD"},{"executeDate":"2016-04-13","recordDate":"2016-04-15","paymentDate":"2016-04-29","value":0.82,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MAA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2593,"buy":0.2593,"hold":0.4074,"sell":0.037,"strongSell":0.037,"meanLabel":"BUY","meanPercent":0.2593,"analysts":27,"updateTime":1741579200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MAA\",params:#withValueCompare:true,withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MAA","date":"2025-03-17","current":36.188954,"percent":0.532298,"low":24.03246,"twenty":28.272434,"median":35.558384,"eighty":54.743841,"high":84.029395,"avg":40.267258,"sd":13.877285,"marketCap":19091229365},"quantilePoints":[{"date":"2020-03-20","current":29.265982,"twenty":34.684225,"median":47.631705,"eighty":61.231813,"marketCap":10354626450},{"date":"2020-03-27","current":35.988796,"twenty":34.629644,"median":47.631705,"eighty":61.231813,"marketCap":12733232068},{"date":"2020-04-03","current":31.543712,"twenty":34.599369,"median":47.631705,"eighty":61.231813,"marketCap":11160512234},{"date":"2020-04-09","current":39.018454,"twenty":34.600011,"median":47.601538,"eighty":61.228855,"marketCap":13805158069},{"date":"2020-04-17","current":37.964805,"twenty":34.599369,"median":47.631705,"eighty":61.231813,"marketCap":13432365545},{"date":"2020-04-24","current":35.599949,"twenty":34.599369,"median":47.631705,"eighty":61.231813,"marketCap":12595653436},{"date":"2020-05-01","current":36.670322,"twenty":34.599369,"median":47.631705,"eighty":61.231813,"marketCap":12974363301},{"date":"2020-05-08","current":41.874731,"twenty":34.599369,"median":46.890933,"eighty":61.231813,"marketCap":13684620239},{"date":"2020-05-15","current":38.722441,"twenty":34.599369,"median":46.449506,"eighty":61.231813,"marketCap":12654455005},{"date":"2020-05-22","current":41.407323,"twenty":34.599369,"median":45.841882,"eighty":61.231813,"marketCap":13531871601},{"date":"2020-05-29","current":42.160973,"twenty":34.599369,"median":45.603935,"eighty":61.231813,"marketCap":13778163978},{"date":"2020-06-05","current":45.088618,"twenty":34.599369,"median":45.030386,"eighty":61.231813,"marketCap":14734915138},{"date":"2020-06-12","current":43.146517,"twenty":34.599369,"median":44.935048,"eighty":61.231813,"marketCap":14100238626},{"date":"2020-06-19","current":41.552255,"twenty":34.599369,"median":44.783758,"eighty":61.231813,"marketCap":13579235519},{"date":"2020-06-26","current":39.95437,"twenty":34.599369,"median":44.434418,"eighty":61.231813,"marketCap":13057048315},{"date":"2020-07-02","current":42.584902,"twenty":34.599369,"median":44.24396,"eighty":61.231813,"marketCap":13916703441},{"date":"2020-07-10","current":41.160937,"twenty":34.599369,"median":43.933346,"eighty":61.231813,"marketCap":13451352939},{"date":"2020-07-17","current":40.914551,"twenty":34.599369,"median":43.481592,"eighty":61.231813,"marketCap":13370834277},{"date":"2020-07-24","current":40.316703,"twenty":34.599369,"median":43.208907,"eighty":61.231813,"marketCap":13175458112},{"date":"2020-07-31","current":41.521368,"twenty":34.599369,"median":43.010643,"eighty":61.231813,"marketCap":14114939873},{"date":"2020-08-07","current":40.580788,"twenty":34.599369,"median":42.773426,"eighty":61.01076,"marketCap":13795195451},{"date":"2020-08-14","current":40.012957,"twenty":34.599369,"median":42.6157,"eighty":60.85923,"marketCap":13602164559},{"date":"2020-08-21","current":40.005989,"twenty":34.599369,"median":42.459856,"eighty":60.697752,"marketCap":13599796082},{"date":"2020-08-28","current":40.814191,"twenty":34.599369,"median":42.307962,"eighty":60.444987,"marketCap":13874539437},{"date":"2020-09-04","current":41.228743,"twenty":34.599369,"median":42.168251,"eighty":60.249224,"marketCap":14015463831},{"date":"2020-09-11","current":40.378738,"twenty":34.599369,"median":42.138771,"eighty":60.090496,"marketCap":13726509612},{"date":"2020-09-18","current":40.037342,"twenty":34.599369,"median":42.03192,"eighty":59.983517,"marketCap":13610454229},{"date":"2020-09-25","current":40.194105,"twenty":34.599369,"median":41.95554,"eighty":59.915214,"marketCap":13663744966},{"date":"2020-10-02","current":43.095968,"twenty":34.599369,"median":41.875831,"eighty":59.627144,"marketCap":14650215720},{"date":"2020-10-09","current":43.07855,"twenty":34.599369,"median":41.875831,"eighty":59.42782,"marketCap":14644294527},{"date":"2020-10-16","current":41.608459,"twenty":34.599369,"median":41.861486,"eighty":59.256223,"marketCap":14144545838},{"date":"2020-10-23","current":41.354154,"twenty":34.599369,"median":41.799047,"eighty":59.087384,"marketCap":14058096420},{"date":"2020-10-30","current":43.000868,"twenty":34.599369,"median":41.774357,"eighty":58.94101,"marketCap":13812265804},{"date":"2020-11-06","current":45.227784,"twenty":34.599369,"median":41.774357,"eighty":58.676016,"marketCap":14527571346},{"date":"2020-11-13","current":48.796749,"twenty":34.599369,"median":41.774357,"eighty":58.56315,"marketCap":15673955064},{"date":"2020-11-20","current":46.521903,"twenty":34.599369,"median":41.774357,"eighty":58.404477,"marketCap":14943253872},{"date":"2020-11-27","current":45.718148,"twenty":34.599369,"median":41.774357,"eighty":58.319582,"marketCap":14685080680},{"date":"2020-12-04","current":46.134773,"twenty":34.599369,"median":41.774357,"eighty":58.197987,"marketCap":14818904399},{"date":"2020-12-11","current":44.855403,"twenty":34.599369,"median":41.774357,"eighty":58.096335,"marketCap":14407958996},{"date":"2020-12-18","current":45.732896,"twenty":34.599369,"median":41.774357,"eighty":57.989471,"marketCap":14689817802},{"date":"2020-12-24","current":45.939365,"twenty":34.599369,"median":41.774357,"eighty":57.903573,"marketCap":14756137522},{"date":"2020-12-31","current":46.709937,"twenty":34.599369,"median":41.774357,"eighty":57.872651,"marketCap":15003652188},{"date":"2021-01-08","current":46.186391,"twenty":34.599369,"median":41.774357,"eighty":57.717721,"marketCap":14835484328},{"date":"2021-01-15","current":48.671393,"twenty":34.599369,"median":41.774357,"eighty":57.596132,"marketCap":15633689520},{"date":"2021-01-22","current":49.471461,"twenty":34.599369,"median":41.774357,"eighty":57.561686,"marketCap":15890678432},{"date":"2021-01-29","current":48.944227,"twenty":34.599369,"median":41.774357,"eighty":57.414527,"marketCap":15721326292},{"date":"2021-02-05","current":62.5765,"twenty":34.599369,"median":41.774357,"eighty":57.372555,"marketCap":15954629590},{"date":"2021-02-12","current":64.165066,"twenty":34.599369,"median":41.774357,"eighty":57.372555,"marketCap":16359653589},{"date":"2021-02-19","current":63.910529,"twenty":34.599369,"median":41.774357,"eighty":57.372555,"marketCap":16294756403},{"date":"2021-02-26","current":62.591158,"twenty":34.599369,"median":41.774357,"eighty":57.372555,"marketCap":15958366869},{"date":"2021-03-05","current":62.210213,"twenty":34.598727,"median":41.766265,"eighty":57.351603,"marketCap":15861240314},{"date":"2021-03-12","current":65.866358,"twenty":34.598727,"median":41.766265,"eighty":57.351603,"marketCap":16793418353},{"date":"2021-03-19","current":65.74557,"twenty":34.598727,"median":41.766265,"eighty":57.351603,"marketCap":16762622128},{"date":"2021-03-26","current":69.030062,"twenty":34.599369,"median":41.774357,"eighty":57.372555,"marketCap":17600042553},{"date":"2021-04-01","current":68.124155,"twenty":34.599369,"median":41.774357,"eighty":57.372555,"marketCap":17369070866},{"date":"2021-04-09","current":68.232379,"twenty":34.598727,"median":41.766265,"eighty":57.351603,"marketCap":17396663814},{"date":"2021-04-16","current":70.169928,"twenty":34.598727,"median":41.766265,"eighty":57.351603,"marketCap":17890665095},{"date":"2021-04-23","current":72.107476,"twenty":34.598727,"median":41.766265,"eighty":57.351603,"marketCap":18384666376},{"date":"2021-04-30","current":70.242521,"twenty":34.598727,"median":41.766265,"eighty":57.351603,"marketCap":18649880893},{"date":"2021-05-07","current":70.108581,"twenty":34.598727,"median":41.766265,"eighty":57.38017,"marketCap":18614318926},{"date":"2021-05-14","current":69.98357,"twenty":34.598727,"median":41.790724,"eighty":57.537607,"marketCap":18581127757},{"date":"2021-05-21","current":70.11751,"twenty":34.598727,"median":41.832101,"eighty":57.585119,"marketCap":18616689724},{"date":"2021-05-28","current":71.747111,"twenty":34.598727,"median":41.876931,"eighty":57.678823,"marketCap":19049360323},{"date":"2021-06-04","current":73.903543,"twenty":34.598727,"median":41.942511,"eighty":57.848141,"marketCap":19621907991},{"date":"2021-06-11","current":76.591269,"twenty":34.598727,"median":42.022435,"eighty":57.891383,"marketCap":20335518129},{"date":"2021-06-18","current":74.93488,"twenty":34.598727,"median":42.160973,"eighty":57.999931,"marketCap":19895735137},{"date":"2021-06-25","current":75.966217,"twenty":34.598727,"median":42.3204,"eighty":58.102416,"marketCap":20169562283},{"date":"2021-07-02","current":76.32339,"twenty":34.598727,"median":42.349313,"eighty":58.198668,"marketCap":20264394195},{"date":"2021-07-09","current":80.676435,"twenty":34.598727,"median":42.349313,"eighty":58.319068,"marketCap":21420158123},{"date":"2021-07-16","current":82.471229,"twenty":34.598727,"median":42.349313,"eighty":58.404903,"marketCap":21896688480},{"date":"2021-07-23","current":83.757051,"twenty":34.598727,"median":42.349313,"eighty":58.56315,"marketCap":22238083364},{"date":"2021-07-30","current":56.251099,"twenty":34.604413,"median":42.349386,"eighty":58.574016,"marketCap":22889865838},{"date":"2021-08-06","current":56.176252,"twenty":34.673349,"median":42.632005,"eighty":58.574016,"marketCap":22859408826},{"date":"2021-08-13","current":55.364787,"twenty":34.710929,"median":42.765023,"eighty":58.574016,"marketCap":22529205401},{"date":"2021-08-20","current":55.943985,"twenty":34.761589,"median":42.849974,"eighty":58.574016,"marketCap":22764894078},{"date":"2021-08-27","current":55.629395,"twenty":34.838792,"median":43.07855,"eighty":58.574016,"marketCap":22636880431},{"date":"2021-09-03","current":57.666876,"twenty":34.90251,"median":43.371175,"eighty":58.574016,"marketCap":23465978161},{"date":"2021-09-10","current":55.711718,"twenty":34.957463,"median":44.041364,"eighty":58.574016,"marketCap":22670379329},{"date":"2021-09-17","current":55.12076,"twenty":35.010191,"median":44.345837,"eighty":58.574016,"marketCap":22429905096},{"date":"2021-09-24","current":55.649976,"twenty":35.041028,"median":44.778625,"eighty":58.574016,"marketCap":22645255156},{"date":"2021-10-01","current":55.632335,"twenty":35.09564,"median":44.919102,"eighty":58.574016,"marketCap":22638076820},{"date":"2021-10-08","current":56.208593,"twenty":35.131351,"median":45.224097,"eighty":58.574016,"marketCap":22872569107},{"date":"2021-10-15","current":58.084368,"twenty":35.177687,"median":45.287017,"eighty":58.574016,"marketCap":23635865430},{"date":"2021-10-22","current":59.336846,"twenty":35.209243,"median":45.548549,"eighty":58.677554,"marketCap":24145527238},{"date":"2021-10-29","current":56.101292,"twenty":35.25107,"median":45.628049,"eighty":58.692006,"marketCap":24207258631},{"date":"2021-11-05","current":55.590306,"twenty":35.358703,"median":45.729209,"eighty":58.692006,"marketCap":23986772361},{"date":"2021-11-12","current":56.329312,"twenty":35.405887,"median":45.820959,"eighty":58.692006,"marketCap":24305647665},{"date":"2021-11-19","current":55.312835,"twenty":35.527026,"median":45.92093,"eighty":58.692006,"marketCap":23867045946},{"date":"2021-11-26","current":55.925469,"twenty":35.589508,"median":45.972548,"eighty":58.692006,"marketCap":24131392387},{"date":"2021-12-03","current":56.985902,"twenty":35.636336,"median":46.097904,"eighty":58.692006,"marketCap":24588960667},{"date":"2021-12-10","current":59.469402,"twenty":35.802241,"median":46.304373,"eighty":58.907142,"marketCap":25660571352},{"date":"2021-12-17","current":60.477638,"twenty":35.981771,"median":46.507155,"eighty":59.069094,"marketCap":26095616840},{"date":"2021-12-23","current":60.738625,"twenty":36.228793,"median":46.529904,"eighty":59.182689,"marketCap":26208230795},{"date":"2021-12-31","current":63.032567,"twenty":36.605106,"median":46.848984,"eighty":59.268156,"marketCap":27198048187},{"date":"2022-01-07","current":59.455666,"twenty":36.732961,"median":47.515535,"eighty":59.411157,"marketCap":25654644302},{"date":"2022-01-14","current":59.095778,"twenty":36.783827,"median":47.890853,"eighty":59.458413,"marketCap":25499355585},{"date":"2022-01-21","current":55.738657,"twenty":36.806375,"median":48.094911,"eighty":59.458413,"marketCap":24050784504},{"date":"2022-01-28","current":56.25239,"twenty":36.865708,"median":48.459428,"eighty":59.458413,"marketCap":24272456183},{"date":"2022-02-04","current":47.198143,"twenty":36.921326,"median":48.533036,"eighty":59.458413,"marketCap":25193943790},{"date":"2022-02-11","current":46.820611,"twenty":36.996514,"median":48.533036,"eighty":59.458413,"marketCap":24992420690},{"date":"2022-02-18","current":45.403123,"twenty":37.014394,"median":48.533036,"eighty":59.458413,"marketCap":24235778323},{"date":"2022-02-25","current":46.61793,"twenty":37.052944,"median":48.533036,"eighty":59.458413,"marketCap":24884231206},{"date":"2022-03-04","current":47.584001,"twenty":37.061671,"median":48.533036,"eighty":59.458413,"marketCap":25399911287},{"date":"2022-03-11","current":46.298127,"twenty":37.135943,"median":48.533036,"eighty":59.458413,"marketCap":24713523318},{"date":"2022-03-18","current":45.920582,"twenty":37.286004,"median":48.533036,"eighty":59.458413,"marketCap":24511993171},{"date":"2022-03-25","current":45.829527,"twenty":37.362791,"median":48.533036,"eighty":59.458413,"marketCap":24463388842},{"date":"2022-04-01","current":47.37524,"twenty":37.41736,"median":48.533036,"eighty":59.458413,"marketCap":25288476971},{"date":"2022-04-08","current":47.599724,"twenty":37.49949,"median":48.533036,"eighty":59.458413,"marketCap":25408304321},{"date":"2022-04-14","current":45.614274,"twenty":37.651586,"median":48.533036,"eighty":59.458413,"marketCap":24348488893},{"date":"2022-04-22","current":45.987379,"twenty":37.833651,"median":48.533036,"eighty":59.458413,"marketCap":24547648840},{"date":"2022-04-29","current":39.056152,"twenty":37.922811,"median":48.533036,"eighty":59.458413,"marketCap":23332145056},{"date":"2022-05-06","current":36.647411,"twenty":37.922811,"median":48.533036,"eighty":59.458413,"marketCap":21893163362},{"date":"2022-05-13","current":35.696227,"twenty":37.922811,"median":48.533036,"eighty":59.458413,"marketCap":21324925744},{"date":"2022-05-20","current":34.812558,"twenty":37.922811,"median":48.533036,"eighty":59.458413,"marketCap":20797022319},{"date":"2022-05-27","current":36.50245,"twenty":37.922811,"median":48.533036,"eighty":59.458413,"marketCap":21806563475},{"date":"2022-06-03","current":35.571123,"twenty":37.833651,"median":48.533036,"eighty":59.458413,"marketCap":21250188854},{"date":"2022-06-10","current":33.392732,"twenty":37.685572,"median":48.533036,"eighty":59.458413,"marketCap":19948817941},{"date":"2022-06-17","current":32.276728,"twenty":37.428715,"median":48.533036,"eighty":59.458413,"marketCap":19282117436},{"date":"2022-06-24","current":34.260514,"twenty":37.193467,"median":48.568159,"eighty":59.46116,"marketCap":20467230966},{"date":"2022-07-01","current":34.840359,"twenty":36.740565,"median":48.568159,"eighty":59.46116,"marketCap":20813630517},{"date":"2022-07-08","current":33.724356,"twenty":36.264918,"median":48.568159,"eighty":59.46116,"marketCap":20146930012},{"date":"2022-07-15","current":33.259685,"twenty":35.937696,"median":48.568159,"eighty":59.46116,"marketCap":19869335852},{"date":"2022-07-22","current":34.562351,"twenty":35.775657,"median":48.568159,"eighty":59.46116,"marketCap":20647548541},{"date":"2022-07-29","current":37.245331,"twenty":35.596613,"median":48.497869,"eighty":59.46116,"marketCap":22035231747},{"date":"2022-08-05","current":36.004021,"twenty":35.596613,"median":48.200254,"eighty":59.46116,"marketCap":21300842663},{"date":"2022-08-12","current":37.658433,"twenty":35.596613,"median":47.986154,"eighty":59.46116,"marketCap":22279632638},{"date":"2022-08-19","current":36.872336,"twenty":35.596613,"median":47.601538,"eighty":59.46116,"marketCap":21814559098},{"date":"2022-08-26","current":34.868994,"twenty":35.505326,"median":47.469448,"eighty":59.46116,"marketCap":20629333420},{"date":"2022-09-02","current":32.931827,"twenty":35.358703,"median":47.306394,"eighty":59.46116,"marketCap":19483259341},{"date":"2022-09-09","current":34.632362,"twenty":35.280971,"median":47.093192,"eighty":59.46116,"marketCap":20489336794},{"date":"2022-09-16","current":33.278752,"twenty":35.234979,"median":46.922361,"eighty":59.46116,"marketCap":19688508633},{"date":"2022-09-23","current":31.718592,"twenty":35.203701,"median":46.746913,"eighty":59.46116,"marketCap":18765480027},{"date":"2022-09-30","current":31.096934,"twenty":35.167217,"median":46.61039,"eighty":59.46116,"marketCap":18397692279},{"date":"2022-10-07","current":29.125676,"twenty":35.09564,"median":46.549676,"eighty":59.46116,"marketCap":17231449195},{"date":"2022-10-14","current":28.544125,"twenty":35.04802,"median":46.514529,"eighty":59.46116,"marketCap":16887389689},{"date":"2022-10-21","current":29.985971,"twenty":35.013348,"median":46.338703,"eighty":59.46116,"marketCap":17740419981},{"date":"2022-10-28","current":29.526208,"twenty":34.952542,"median":46.233722,"eighty":59.46116,"marketCap":18585448534},{"date":"2022-11-04","current":28.981346,"twenty":34.846082,"median":46.158213,"eighty":59.46116,"marketCap":18242482272},{"date":"2022-11-11","current":30.218125,"twenty":34.815979,"median":46.097904,"eighty":59.46116,"marketCap":19020980085},{"date":"2022-11-18","current":29.922128,"twenty":34.710929,"median":45.976501,"eighty":59.46116,"marketCap":18834662773},{"date":"2022-11-25","current":30.440594,"twenty":34.679761,"median":45.939365,"eighty":59.46116,"marketCap":19161014752},{"date":"2022-12-02","current":30.968488,"twenty":34.607753,"median":45.912473,"eighty":59.46116,"marketCap":19493300404},{"date":"2022-12-09","current":30.47453,"twenty":34.564552,"median":45.820959,"eighty":59.46116,"marketCap":19182375973},{"date":"2022-12-16","current":29.712856,"twenty":34.47148,"median":45.732896,"eighty":59.46116,"marketCap":18702935247},{"date":"2022-12-23","current":29.477189,"twenty":34.409089,"median":45.672198,"eighty":59.46116,"marketCap":18554593438},{"date":"2022-12-30","current":29.59785,"twenty":34.397532,"median":45.628049,"eighty":59.46116,"marketCap":18630544444},{"date":"2023-01-06","current":29.846714,"twenty":34.374131,"median":45.589105,"eighty":59.46116,"marketCap":18787193394},{"date":"2023-01-13","current":30.148368,"twenty":34.250829,"median":45.574999,"eighty":59.46116,"marketCap":18977070909},{"date":"2023-01-20","current":29.309394,"twenty":34.191076,"median":45.574999,"eighty":59.46116,"marketCap":18448974070},{"date":"2023-01-27","current":31.098576,"twenty":34.10295,"median":45.532102,"eighty":59.46116,"marketCap":19575185082},{"date":"2023-02-03","current":32.208726,"twenty":34.048791,"median":45.532102,"eighty":59.46116,"marketCap":20531001214},{"date":"2023-02-10","current":31.896038,"twenty":34.048791,"median":45.532102,"eighty":59.46116,"marketCap":20331682624},{"date":"2023-02-17","current":31.628321,"twenty":34.048791,"median":45.532102,"eighty":59.46116,"marketCap":20161030348},{"date":"2023-02-24","current":30.797875,"twenty":34.048791,"median":45.532102,"eighty":59.46116,"marketCap":19631674555},{"date":"2023-03-03","current":29.961794,"twenty":34.048791,"median":45.532102,"eighty":59.46116,"marketCap":19098725850},{"date":"2023-03-10","current":28.004047,"twenty":34.048791,"median":45.532102,"eighty":59.46116,"marketCap":17850787533},{"date":"2023-03-17","current":27.297604,"twenty":34.048791,"median":45.532102,"eighty":59.46116,"marketCap":17400475818},{"date":"2023-03-24","current":26.931232,"twenty":34.048791,"median":45.532102,"eighty":59.46116,"marketCap":17166936498},{"date":"2023-03-31","current":28.377935,"twenty":34.035604,"median":45.51636,"eighty":59.458413,"marketCap":18089117404},{"date":"2023-04-06","current":28.03035,"twenty":34.035604,"median":45.51636,"eighty":59.458413,"marketCap":17867554459},{"date":"2023-04-14","current":27.697797,"twenty":34.048791,"median":45.532102,"eighty":59.46116,"marketCap":17655572614},{"date":"2023-04-21","current":28.064176,"twenty":34.048791,"median":45.532102,"eighty":59.46116,"marketCap":17889116117},{"date":"2023-04-28","current":27.351358,"twenty":34.048791,"median":45.532102,"eighty":59.46116,"marketCap":18121477920},{"date":"2023-05-05","current":27.026749,"twenty":34.048791,"median":45.532102,"eighty":59.46116,"marketCap":17906410334},{"date":"2023-05-12","current":27.692245,"twenty":34.052264,"median":45.53979,"eighty":59.463908,"marketCap":18347330976},{"date":"2023-05-19","current":26.833249,"twenty":34.052264,"median":45.53979,"eighty":59.463908,"marketCap":17778207864},{"date":"2023-05-26","current":26.135201,"twenty":34.052264,"median":45.53979,"eighty":59.463908,"marketCap":17315720451},{"date":"2023-06-02","current":26.56922,"twenty":34.061986,"median":45.547478,"eighty":59.466655,"marketCap":17603277392},{"date":"2023-06-09","current":27.677778,"twenty":34.09894,"median":45.548013,"eighty":59.469402,"marketCap":18337745745},{"date":"2023-06-16","current":27.88032,"twenty":34.089701,"median":45.548549,"eighty":59.470341,"marketCap":18471938984},{"date":"2023-06-23","current":26.961646,"twenty":34.027143,"median":45.560229,"eighty":59.47128,"marketCap":17863276793},{"date":"2023-06-29","current":27.175039,"twenty":33.977624,"median":45.571908,"eighty":59.472219,"marketCap":18004658955},{"date":"2023-07-07","current":27.806175,"twenty":33.954705,"median":45.589105,"eighty":59.474097,"marketCap":18422814673},{"date":"2023-07-13","current":28.440929,"twenty":33.855596,"median":45.589105,"eighty":59.474097,"marketCap":18843366699},{"date":"2023-07-21","current":27.782666,"twenty":33.715933,"median":45.60169,"eighty":59.476767,"marketCap":18407238672},{"date":"2023-07-28","current":29.971458,"twenty":33.627961,"median":45.60169,"eighty":59.476767,"marketCap":17908845173},{"date":"2023-08-04","current":29.245476,"twenty":33.518871,"median":45.60169,"eighty":59.476767,"marketCap":17475049519},{"date":"2023-08-11","current":28.916583,"twenty":33.393311,"median":45.60169,"eighty":59.476767,"marketCap":17278525613},{"date":"2023-08-18","current":28.808288,"twenty":33.277549,"median":45.60169,"eighty":59.476767,"marketCap":17213816522},{"date":"2023-08-25","current":28.712027,"twenty":33.208477,"median":45.60169,"eighty":59.476767,"marketCap":17156297330},{"date":"2023-09-01","current":29.125149,"twenty":32.982882,"median":45.60169,"eighty":59.476767,"marketCap":17403150529},{"date":"2023-09-08","current":28.106381,"twenty":32.737415,"median":45.60169,"eighty":59.476767,"marketCap":16794405747},{"date":"2023-09-15","current":27.669193,"twenty":32.380704,"median":45.60169,"eighty":59.476767,"marketCap":16533172750},{"date":"2023-09-22","current":26.508037,"twenty":32.189002,"median":45.614274,"eighty":59.479437,"marketCap":15839347497},{"date":"2023-09-29","current":25.858271,"twenty":32.068685,"median":45.614274,"eighty":59.479437,"marketCap":15451092951},{"date":"2023-10-06","current":25.741955,"twenty":31.877198,"median":45.614274,"eighty":59.479437,"marketCap":15381590594},{"date":"2023-10-13","current":26.415787,"twenty":31.682484,"median":45.614274,"eighty":59.479437,"marketCap":15784224938},{"date":"2023-10-20","current":26.25134,"twenty":31.487098,"median":45.614274,"eighty":59.479437,"marketCap":15685962985},{"date":"2023-10-27","current":24.911812,"twenty":31.245329,"median":45.619684,"eighty":59.487446,"marketCap":14597101350},{"date":"2023-11-03","current":24.701221,"twenty":31.070307,"median":45.619684,"eighty":59.487446,"marketCap":14473705239},{"date":"2023-11-10","current":24.496707,"twenty":30.960946,"median":45.619684,"eighty":59.487446,"marketCap":14353869958},{"date":"2023-11-17","current":24.909826,"twenty":30.806158,"median":45.619684,"eighty":59.487446,"marketCap":14595937225},{"date":"2023-11-24","current":25.085712,"twenty":30.667609,"median":45.619684,"eighty":59.487446,"marketCap":14698997763},{"date":"2023-12-01","current":24.789206,"twenty":30.47453,"median":45.619684,"eighty":59.487446,"marketCap":14525260124},{"date":"2023-12-08","current":25.32689,"twenty":30.399117,"median":45.619684,"eighty":59.487446,"marketCap":14840316377},{"date":"2023-12-15","current":27.571221,"twenty":30.278456,"median":45.619684,"eighty":59.487446,"marketCap":16155384513},{"date":"2023-12-22","current":26.292729,"twenty":30.148368,"median":45.619684,"eighty":59.487446,"marketCap":15406250757},{"date":"2023-12-29","current":27.192851,"twenty":30.046908,"median":45.620766,"eighty":59.493623,"marketCap":15933678261},{"date":"2024-01-05","current":26.318617,"twenty":30.002527,"median":45.627057,"eighty":59.4998,"marketCap":15421420132},{"date":"2024-01-12","current":26.67309,"twenty":29.872514,"median":45.627057,"eighty":59.4998,"marketCap":15629123883},{"date":"2024-01-19","current":26.179218,"twenty":29.787951,"median":45.633348,"eighty":59.505978,"marketCap":15339738881},{"date":"2024-01-26","current":26.282772,"twenty":29.709085,"median":45.627057,"eighty":59.4998,"marketCap":15400416381},{"date":"2024-02-02","current":25.474255,"twenty":29.622514,"median":45.60169,"eighty":59.4998,"marketCap":14926665127},{"date":"2024-02-09","current":26.276974,"twenty":29.55298,"median":45.51636,"eighty":59.4998,"marketCap":14526069120},{"date":"2024-02-16","current":27.343845,"twenty":29.455852,"median":45.344528,"eighty":59.4998,"marketCap":15115841629},{"date":"2024-02-23","current":26.727336,"twenty":29.396087,"median":45.235158,"eighty":59.4998,"marketCap":14775031981},{"date":"2024-03-01","current":26.535205,"twenty":29.307886,"median":45.172322,"eighty":59.493623,"marketCap":14668820755},{"date":"2024-03-08","current":28.015248,"twenty":29.262282,"median":44.919102,"eighty":59.493623,"marketCap":15486997342},{"date":"2024-03-15","current":27.504306,"twenty":29.207448,"median":44.77429,"eighty":59.493623,"marketCap":15204545510},{"date":"2024-03-22","current":28.068032,"twenty":29.124347,"median":43.874805,"eighty":59.493623,"marketCap":15516176251},{"date":"2024-03-28","current":27.616207,"twenty":29.0353,"median":43.266666,"eighty":59.493623,"marketCap":15266404796},{"date":"2024-04-05","current":26.778008,"twenty":28.932626,"median":43.03547,"eighty":59.4998,"marketCap":14803043733},{"date":"2024-04-12","current":27.870195,"twenty":28.842236,"median":42.761922,"eighty":59.4998,"marketCap":15406810852},{"date":"2024-04-19","current":26.313991,"twenty":28.709651,"median":42.6157,"eighty":59.4998,"marketCap":14546532074},{"date":"2024-04-26","current":26.858768,"twenty":28.58503,"median":42.3204,"eighty":59.493623,"marketCap":14847688010},{"date":"2024-05-03","current":27.415968,"twenty":28.524555,"median":41.874731,"eighty":59.493623,"marketCap":15370625449},{"date":"2024-05-10","current":28.410238,"twenty":28.458191,"median":41.552255,"eighty":59.493623,"marketCap":15928057658},{"date":"2024-05-17","current":28.518594,"twenty":28.439397,"median":41.436309,"eighty":59.493623,"marketCap":15988807181},{"date":"2024-05-24","current":27.697585,"twenty":28.404416,"median":41.333252,"eighty":59.493623,"marketCap":15528512717},{"date":"2024-05-31","current":27.059949,"twenty":28.373143,"median":41.228743,"eighty":59.493623,"marketCap":15171025139},{"date":"2024-06-07","current":28.566521,"twenty":28.339207,"median":41.139197,"eighty":59.493623,"marketCap":16015677162},{"date":"2024-06-14","current":28.799904,"twenty":28.339025,"median":40.943538,"eighty":59.4998,"marketCap":16146522289},{"date":"2024-06-21","current":29.212492,"twenty":28.338843,"median":40.914551,"eighty":59.482106,"marketCap":16377837781},{"date":"2024-06-28","current":29.285425,"twenty":28.334671,"median":40.805482,"eighty":59.493623,"marketCap":16418726883},{"date":"2024-07-05","current":29.054125,"twenty":28.334671,"median":40.779991,"eighty":59.470341,"marketCap":16289050016},{"date":"2024-07-12","current":29.372943,"twenty":28.334671,"median":40.680913,"eighty":59.357565,"marketCap":16467793805},{"date":"2024-07-15","current":29.306262,"twenty":28.334671,"median":40.650115,"eighty":59.34028,"marketCap":16430409483},{"date":"2024-08-02","current":33.104108,"twenty":28.293795,"median":40.542468,"eighty":59.127894,"marketCap":17111844295},{"date":"2024-08-09","current":34.60997,"twenty":28.293795,"median":40.424025,"eighty":58.879912,"marketCap":17890239780},{"date":"2024-08-16","current":34.67328,"twenty":28.293795,"median":40.345689,"eighty":58.674993,"marketCap":17922965116},{"date":"2024-08-23","current":34.867731,"twenty":28.293795,"median":40.262353,"eighty":58.416866,"marketCap":18023478647},{"date":"2024-08-30","current":36.425598,"twenty":28.293795,"median":40.044954,"eighty":58.089364,"marketCap":18828755658},{"date":"2024-09-06","current":36.436903,"twenty":28.293795,"median":40.005989,"eighty":57.980974,"marketCap":18834599468},{"date":"2024-09-13","current":37.18079,"twenty":28.293795,"median":39.838969,"eighty":57.818026,"marketCap":19219122163},{"date":"2024-09-20","current":37.196617,"twenty":28.293795,"median":39.462543,"eighty":57.670964,"marketCap":19227303497},{"date":"2024-09-27","current":35.887466,"twenty":28.293795,"median":39.1525,"eighty":57.520628,"marketCap":18550590305},{"date":"2024-10-04","current":35.08027,"twenty":28.293795,"median":38.13874,"eighty":57.208427,"marketCap":18133342274},{"date":"2024-10-11","current":34.41552,"twenty":28.293795,"median":37.812845,"eighty":56.890245,"marketCap":17789726249},{"date":"2024-10-18","current":34.585099,"twenty":28.293795,"median":37.676041,"eighty":56.632028,"marketCap":17877383399},{"date":"2024-10-25","current":35.288287,"twenty":28.293795,"median":37.436308,"eighty":56.407343,"marketCap":18240868377},{"date":"2024-10-31","current":34.107469,"twenty":28.293795,"median":37.23731,"eighty":56.320316,"marketCap":17782713677},{"date":"2024-11-08","current":34.678075,"twenty":28.291515,"median":37.055008,"eighty":56.224881,"marketCap":18080212214},{"date":"2024-11-15","current":35.278872,"twenty":28.291515,"median":36.980686,"eighty":56.176252,"marketCap":18393451394},{"date":"2024-11-22","current":35.538918,"twenty":28.291515,"median":36.863767,"eighty":56.049094,"marketCap":18529032532},{"date":"2024-11-29","current":36.80104,"twenty":28.291515,"median":36.760247,"eighty":55.943985,"marketCap":19187068570},{"date":"2024-12-06","current":35.686876,"twenty":28.291515,"median":36.612136,"eighty":55.889755,"marketCap":18606173524},{"date":"2024-12-13","current":35.498566,"twenty":28.291515,"median":36.457093,"eighty":55.738657,"marketCap":18507994079},{"date":"2024-12-20","current":33.4989,"twenty":28.291515,"median":36.300667,"eighty":55.649976,"marketCap":17465421884},{"date":"2024-12-27","current":34.79689,"twenty":28.291515,"median":36.228793,"eighty":55.629395,"marketCap":18142158769},{"date":"2025-01-03","current":34.180401,"twenty":28.291515,"median":36.0749,"eighty":55.43829,"marketCap":17820737968},{"date":"2025-01-10","current":33.478724,"twenty":28.281974,"median":35.971234,"eighty":55.314483,"marketCap":17454902657},{"date":"2025-01-17","current":33.767913,"twenty":28.281974,"median":35.887466,"eighty":55.127816,"marketCap":17605678233},{"date":"2025-01-24","current":32.93173,"twenty":28.281974,"median":35.86846,"eighty":54.86556,"marketCap":17169714747},{"date":"2025-01-31","current":34.039168,"twenty":28.281974,"median":35.814657,"eighty":54.736785,"marketCap":17747103385},{"date":"2025-02-07","current":35.197194,"twenty":28.281974,"median":35.696227,"eighty":54.736785,"marketCap":18568033380},{"date":"2025-02-14","current":34.788463,"twenty":28.281974,"median":35.672666,"eighty":54.736785,"marketCap":18352410128},{"date":"2025-02-21","current":35.473197,"twenty":28.281974,"median":35.545644,"eighty":54.736785,"marketCap":18713636622},{"date":"2025-02-28","current":36.984486,"twenty":28.281974,"median":35.545644,"eighty":54.736785,"marketCap":19510906748},{"date":"2025-03-07","current":36.955679,"twenty":28.272434,"median":35.544523,"eighty":54.743841,"marketCap":19495709517},{"date":"2025-03-14","current":35.841047,"twenty":28.272434,"median":35.544523,"eighty":54.743841,"marketCap":18907693573},{"date":"2025-03-17","current":36.188954,"twenty":28.272434,"median":35.558384,"eighty":54.743841,"marketCap":19091229365}],"customCompares":[],"updateTime":1742337152492},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MAA\",pageSize:16,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2517860215","title":"Mid-America Apartment Communities (NYSE:MAA) Declares US$1 Dividend For Series I Preferred Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2517860215","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517860215?lang=en_us&edition=fundamental","pubTime":"2025-03-05 01:39","pubTimestamp":1741109957,"startTime":"0","endTime":"0","summary":"Mid-America Apartment Communities saw a notable price move of 12% over the past month, which may be attributed to its recent announcements and broader market dynamics. The company declared a quarterly dividend for its preferred stock, providing a consistent yield of 8.5%, coinciding with a favorable annual outlook compared to earnings guidance for 2025. This announcement followed revising its earnings trajectory, with future diluted EPS expected to rise significantly. Meanwhile, the broader market grappled with volatility due to tariffs and concerns over global economic health, reflected in the Dow Jones and S&P 500 drops. Nevertheless, while MAA and similar sectors faced these pressures, investor confidence possibly shifted positively due to its solid dividend commitment and future prospects, diverging from the broader 2.5% market downturn over the same period. Despite this uncertainty, Mid-America's strategic communication and financial stability might have contributed to its recent ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/mid-america-apartment-communities-nyse-173917611.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MAA","BK4585","NYSE","BK4215","BK4588"],"gpt_icon":0},{"id":"2516795661","title":"Mid-America Apartment Communities Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2516795661","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516795661?lang=en_us&edition=fundamental","pubTime":"2025-03-04 06:08","pubTimestamp":1741039680,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Mid-America Apartment Communities Inc.  advanced 1.67% to $170.92 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 1.76% to 5,849.72 and Dow Jones Industrial Average  falling 1.48% to 43,191.24.This was the stock's third consecutive day of gains.Mid-America Apartment Communities Inc. hit a new 52-week high, surpassing its previous peak of $169.05, which the company reached on February 28th.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Avalonbay Communities Inc.  rose 0.84% to $228.08, Equity Residential  rose 1.15% to $75.02, and UDR Inc.  rose 1.90% to $46.04.Trading volume  eclipsed its 50-day average volume of 741,557.Data source: Dow Jones Market Data, FactSet. Data compiled March 3, 2025.This content was created by MarketWatch, which is operated by Dow Jones &","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAA"],"gpt_icon":0},{"id":"2516666895","title":"Press Release: MAA Announces Regular Quarterly Preferred Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2516666895","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516666895?lang=en_us&edition=fundamental","pubTime":"2025-03-04 05:15","pubTimestamp":1741036500,"startTime":"0","endTime":"0","summary":"GERMANTOWN, Tenn., March 3, 2025 /PRNewswire/ -- Mid-America Apartment Communities, Inc., or MAA , today announced a full quarterly dividend of $1.0625 per outstanding share of its 8.50% Series I Cumulative Redeemable Preferred Stock.  The dividend is payable on March 31, 2025, to shareholders of record on March 14, 2025.MAA is a self-administered real estate investment trust  and member of the S&P 500. MAA owns or has ownership interest in apartment communities primarily throughout the Southeast, Southwest and Mid-Atlantic regions of the U.S. focused on delivering strong, full-cycle investment performance. For further details, please refer to the \"For Investors\" page at www.maac.com or contact Investor Relations at investor.relations@maac.com./CONTACT: Investor Relations of MAA, 866-576-9689 , +1-901-682-6600, investor.relations@maac.com.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAA","BK4585","BK4588","BK4215","REIT","CFA.SI"],"gpt_icon":0},{"id":"2516631653","title":"Acadia Pharmaceuticals and Saniona Announce Initial Positive Results from ACP-711 (formerly SAN711) Phase 1 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2516631653","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516631653?lang=en_us&edition=fundamental","pubTime":"2025-03-03 22:05","pubTimestamp":1741010700,"startTime":"0","endTime":"0","summary":"SAN DIEGO & COPENHAGEN, Denmark, March 03, 2025----Acadia Pharmaceuticals Inc.  and Saniona  today announced the successful completion of the two originally planned cohorts in their Phase 1 multiple-ascending-dose MAD study  of ACP-711, formerly SAN711, in healthy volunteers.In the study, ACP-711 was safe and generally well tolerated across all dosing cohorts. There were no serious adverse events, and all participants completed the study. Most adverse events were mild. No safety laboratory concerns, cardiovascular concerns, or abnormal neurological findings were observed.Given the favorable safety and tolerability profile and the prioritization of essential tremor as the lead indication, Acadia Pharmaceuticals and Saniona are seeking regulatory approval to evaluate ACP-711 in elderly healthy volunteers and to test higher repeated doses. To enable this extension, the study has been temporarily paused until regulatory approval.This press release contains forward-looking statements within","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/acadia-pharmaceuticals-saniona-announce-initial-140500878.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4215","BK4080","ACAD","LU2065170008.USD","MAA","AKR","BK4588","LU2065169927.USD","BK4139","ACP","LU2065171311.SGD","BK4231","BK4585","LU2065171402.SGD"],"gpt_icon":0},{"id":"2516112639","title":"Ocugen Announces Positive Opinion of EMA’s Committee for Advanced Therapies for ATMP Classification for Novel Modifier Gene Therapy Candidate OCU410 for Geographic Atrophy and OCU410ST for Stargardt Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2516112639","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516112639?lang=en_us&edition=fundamental","pubTime":"2025-03-03 22:00","pubTimestamp":1741010400,"startTime":"0","endTime":"0","summary":"MALVERN, Pa., March 03, 2025  -- Ocugen, Inc.  , a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the European Commission has provided a positive opinion from the European Medicines Agency’s  Committee for Advanced Therapies  for OCU410 and OCU410ST Advanced Therapy Medicinal Product  classification. OCU410 is a novel, multifunctional modifier gene therapy candidate being developed for the treatment of patients with vision loss due to geographic atrophy —an advanced stage of dry age-related macular degeneration —and OCU410ST is being developed for Stargardt disease due to ABCA4-related retinopathies.GA affects 2-3 million people in the United States  and Europe combined. There are two approved therapies in the U.S. that require frequent dosing , however neither therapy has been approved in Europe. Stargardt disease affects 100,000 people in the U.S. and Europe combined, and there are no approved treatments available globally.6-month data ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ocugen-announces-positive-opinion-ema-140000451.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2264538146.SGD","IE0031619046.USD","IE00B7SZL793.SGD","MAA","LU2023250504.SGD","BK4139","AEIS","BK4520","BK4157","IE00BSNM7G36.USD","BK4585","IE00B19Z4B17.USD","BK4597","BK4568","LU1064131342.USD","LU1974910355.USD","IE00BD6J9T35.USD","BK4215","LU0942090050.USD","LU0868494708.USD","LU2106854487.HKD","LU2237438978.USD","LU0868494617.USD","LU1917777945.USD","BK4516","CAT","OCGN","BK4532","IE00B66KJ199.SGD","BK4149","ATMP","LU1988902786.USD","BK4563","BK4588"],"gpt_icon":0},{"id":"2516635992","title":"Acurx Announces Publication of Nonclinical In Vivo Data Differentiating Ibezapolstat's Gut Microbiome Effects from Other Anti-CDI Antibiotics","url":"https://stock-news.laohu8.com/highlight/detail?id=2516635992","media":"CNW Group","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516635992?lang=en_us&edition=fundamental","pubTime":"2025-03-03 21:00","pubTimestamp":1741006800,"startTime":"0","endTime":"0","summary":"First ever head-to-head comparison of gut microbiome changes associated with ibezapolstat  to other anti-CDI antibiotics in a germ-free mouse model. Changes in alpha and beta microbiome diversities following IBZ treatment were less pronounced compared to those observed in vancomycin -or metronidazole -treated groups, complementing prior Phase 2 clinical findings showing IBZ's more selective antibacterial activity. Notable differences were observed between the microbiome of IBZ- and fidaxomicin -treated groups, which may allow for differentiation of these two anti-CDI antibiotics in future studies. Results establish IBZ differentiating effects on the gut microbiome, indicating a more selective spectrum of microbiome alteration compared to broader-spectrum antibiotics like VAN and MET and a narrower spectrum of microbiome alteration compared to FDX. Preparation continues to advance IBZ into international Ph3 clinical trials for treatment of CDI. IBZ has previously been granted FDA QIDP a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/acurx-announces-publication-nonclinical-vivo-130000861.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4135","MAA","BK4585","BK4194","PK","LU1989772923.USD","BK4139","LU0052756011.USD","LU0128525689.USD","LU1571399168.USD","NCI","LU0048573561.USD","BK4202","VRE","BK4588","BK4215","FDX","BK4563","GAIN","LU1989771016.USD","BK4539","LU0310800965.SGD","LU0742534661.SGD","ACXP","LU0251142724.SGD","BK4162","LU1496350502.SGD","LU1291159041.SGD","MET","ECC","BK4181","LU1267930227.SGD","BK4218","IDSA","LU0251131958.USD","LU1989772840.SGD","BK4533","BK4131"],"gpt_icon":0},{"id":"2516588141","title":"Mid-America Apartment Highlights Growth at Citi Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2516588141","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516588141?lang=en_us&edition=fundamental","pubTime":"2025-03-01 06:50","pubTimestamp":1740783039,"startTime":"0","endTime":"0","summary":"An announcement from Mid-America Apartment ( ($MAA) ) is now available. Mid-America Apartment Communities (MAA) presented at the 2025 Citi Global P...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mid-america-apartment-highlights-growth-at-citi-conference?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mid-america-apartment-highlights-growth-at-citi-conference?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MAA","BK4585","BK4215","BK4588"],"gpt_icon":0},{"id":"2516024301","title":"MAA to Participate in the 2025 Citi Global Property CEO Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2516024301","media":"PR Newswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516024301?lang=en_us&edition=fundamental","pubTime":"2025-03-01 05:15","pubTimestamp":1740777300,"startTime":"0","endTime":"0","summary":"GERMANTOWN, Tenn., Feb.28, 2025 /PRNewswire/ -- Mid-America Apartment Communities, Inc., or MAA , today announced that the Company plans to participate in the 2025 Citi Global Property CEO Conference.During the conference, H. Eric Bolton, Jr., Chairman and CEO and A. Bradley Hill, President and Chief Investment Officer, along with members of MAA's management team, will host a roundtable discussion on Tuesday, March 4, 2025, at approximately 1:30 p.m. Eastern Time that is expected to last for approximately 35 minutes.The webcast replay will be available on the \"For Investors\" page of MAA's website after the conclusion of the live event.MAA is a self-administered real estate investment trust  and member of the S&P 500. MAA owns or has ownership interest in apartment communities primarily throughout the Southeast, Southwest and Mid-Atlantic regions of the U.S. focused on delivering strong, full-cycle investment performance. For further details, please refer to the \"For Investors\" page at ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/maa-participate-2025-citi-global-211500581.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/maa-participate-2025-citi-global-211500581.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MAA","BK4585","BK4588","REIT","BK4215"],"gpt_icon":0},{"id":"2516737941","title":"Bavarian Nordic Receives Marketing Authorization in Europe for Chikungunya Vaccine for Persons Aged 12 and Older","url":"https://stock-news.laohu8.com/highlight/detail?id=2516737941","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516737941?lang=en_us&edition=fundamental","pubTime":"2025-03-01 00:14","pubTimestamp":1740759240,"startTime":"0","endTime":"0","summary":"First chikungunya vaccine approved in Europe for persons as young as 12 years old.On track for launch in key European markets in the first half of 2025.COPENHAGEN, Denmark, February 28, 2025 – Bavarian Nordic A/S  today announced that the European Commission has granted marketing authorization in Europe for VIMKUNYA for active immunization for the prevention of disease caused by chikungunya virus in individuals 12 years and older.The marketing authorization was granted by the European Commission upon recommendation by the Committee for Medicinal Products for Human Use  of the European Medicines Agency  in January 2025 and was based on results from two phase 3 clinical trials which enrolled more than 3,500 healthy individuals 12 years of age and older. The studies met their primary endpoints, with results showing that 21 days after vaccination, the vaccine induced neutralizing antibodies in up to 97.8% of the vaccinated individuals and demonstrated a rapid immune response starting to de","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bavarian-nordic-receives-marketing-authorization-161400126.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BVNRY","BK4585","VLP","MAA","BK4215","BK4588","CHMP","BK4139","BVNKF","BK4087"],"gpt_icon":0},{"id":"2514321656","title":"Acurx Pharmaceuticals to Discuss Fourth Quarter and Full Year 2024 Financial Results on March 18, 2025 Conference Call and Provide Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2514321656","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514321656?lang=en_us&edition=fundamental","pubTime":"2025-02-28 21:00","pubTimestamp":1740747600,"startTime":"0","endTime":"0","summary":"David P. Luci, President and Chief Executive Officer, and Robert G. Shawah, Chief Financial Officer, will host a conference call to discuss the results and provide a business update as follows:. Click here for participant international Toll-Free access numbers. Acurx previously announced that it had received positive regulatory guidance from the EMA during its Scientific Advice Procedure which confirmed that the clinical, non-clinical and CMC  information package submitted to EMA supports advancement of the ibezapolstat Phase 3 program and if the Phase 3 program is successful, supports the submission of a Marketing Authorization Application  for regulatory approval in Europe. The information package submitted to EMA by the Company to which agreement has been reached with EMA included details on Acurx's two planned international Phase 3 clinical trials, 1:1 randomized , primary and secondary endpoints, sample size, statistical analysis plan and the overall registration safety database. ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/acurx-pharmaceuticals-discuss-fourth-quarter-130000228.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/acurx-pharmaceuticals-discuss-fourth-quarter-130000228.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4215","BK4539","BK4588","BK4135","BK4194","VRE","ACXP","GAIN","BK4585","MAA","BK4139","BK4563"],"gpt_icon":0},{"id":"2514603356","title":"Mid-America Apartment Communities Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2514603356","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514603356?lang=en_us&edition=fundamental","pubTime":"2025-02-28 06:10","pubTimestamp":1740694200,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Mid-America Apartment Communities Inc.  advanced 1.63% to $166.90 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 1.59% to 5,861.57 and Dow Jones Industrial Average  falling 0.45% to 43,239.50.Mid-America Apartment Communities Inc. closed 0.29% short of its 52-week high of $167.39, which the company achieved on September 16th.The stock outperformed some of its competitors Thursday, as Avalonbay Communities Inc.  rose 0.65% to $223.02, Equity Residential  rose 1.18% to $73.68, and UDR Inc.  rose 1.42% to $44.34.Trading volume  eclipsed its 50-day average volume of 725,193.Data source: Dow Jones Market Data, FactSet. Data compiled February 27, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Jour","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAA"],"gpt_icon":0},{"id":"2514358999","title":"89bio Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2514358999","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514358999?lang=en_us&edition=fundamental","pubTime":"2025-02-28 05:05","pubTimestamp":1740690300,"startTime":"0","endTime":"0","summary":"– ENLIGHTEN-Fibrosis and ENLIGHTEN-Cirrhosis Phase 3 trials in patients with non-cirrhotic (F2-F3) and compensated cirrhotic (F4) metabolic dysfunction-associated steatohepatitis (MASH) continue to ad","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/27/3034307/0/en/89bio-Reports-Fourth-Quarter-and-Full-Year-2024-Financial-Results-and-Corporate-Updates.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4090","LU0170899867.USD","IE00BZ1G4Q59.USD","LU0971096721.USD","CMC","MAA","LU0267386448.USD","IE00B1BXHZ80.USD","BK4153","BK4585","BK4215","BK4588","TG","LU1363072403.SGD","BK4006","LU0149725797.USD","IE00BHPRN162.USD","LU0882574139.USD","IE00BKVL7J92.USD"],"gpt_icon":0},{"id":"2514559330","title":"Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Fourth Quarter and Full Year 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2514559330","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514559330?lang=en_us&edition=fundamental","pubTime":"2025-02-28 05:01","pubTimestamp":1740690060,"startTime":"0","endTime":"0","summary":"Significant Demand for Amtagvi (Lifileucel) Continues with Total Product Revenue of $73.7M in 4Q24 and $164.1M in FY24, Achieving Upper End of FY24 Guidance Range of $160M-$165M Reaffirming FY25 Total","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/02/27/3034267/0/en/Iovance-Biotherapeutics-Reports-Financial-Results-and-Corporate-Updates-for-Fourth-Quarter-and-Full-Year-2024.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAA","BK4588","BK4585","BK4505","IOVA","TIL","BK4215","BK4139"],"gpt_icon":0},{"id":"2514885330","title":"Cytokinetics Reports Fourth Quarter 2024 Financial Results  and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2514885330","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514885330?lang=en_us&edition=fundamental","pubTime":"2025-02-28 05:00","pubTimestamp":1740690000,"startTime":"0","endTime":"0","summary":"Commercial Launch Preparations Advancing Prior to September 26 PDUFA Date;Regulatory Filings Under Review in U.S., Europe and China. Topline Results from MAPLE-HCM Expected in Q2 2025. Company Provides 2025 Financial Guidance; ~$1.2 Billion in Cash, Cash Equivalents and Investments as of December 31, 2024. SOUTH SAN FRANCISCO, Calif., Feb. 27, 2025  -- Cytokinetics, Incorporated  reported a management update and financial results for the fourth quarter and full year of 2024. The company also provided full year 2025 financial guidance.The Center for Drug Evaluation  oftheChina National Medical Products Administration  accepted the NDA foraficamtenforthe treatment of obstructive HCM with Priority Review. We are responding to information requests from the NMPA","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cytokinetics-reports-fourth-quarter-2024-210000423.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","BK4215","BK4585","CDE","CHMP","BK4588","BK4017","BK4505","BK4531","CYTK","HCM","BK4087","MAA","BK4139"],"gpt_icon":0},{"id":"2514883683","title":"Analysts Have Conflicting Sentiments on These Real Estate Companies: Mid-America Apartment (MAA) and Outfront Media (OUT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2514883683","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514883683?lang=en_us&edition=fundamental","pubTime":"2025-02-27 22:10","pubTimestamp":1740665412,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Real Estate sector with new ratings on Mid-America Apartment (MAA – Research Report) and Outfront Media...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-real-estate-companies-mid-america-apartment-maa-and-outfront-media-out?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-real-estate-companies-mid-america-apartment-maa-and-outfront-media-out?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4215","BK4588","MAA","BK4585","OUT","BK4084","BK4234"],"gpt_icon":0},{"id":"2514805739","title":"Viridian Therapeutics Highlights Recent Progress and Reports Fourth Quarter and Full Year 2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2514805739","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514805739?lang=en_us&edition=fundamental","pubTime":"2025-02-27 20:00","pubTimestamp":1740657600,"startTime":"0","endTime":"0","summary":"- Reported positive topline phase 3 data for veligrotug from both THRIVE and THRIVE-2 in patients with active and chronic thyroid eye disease ; veligrotug has the potential to transform the standard of care in TED with a differentiated clinical profile achieved with fewer infusions; Biologics License Application  submission on track for second half of 2025 -. - REVEAL-1 and REVEAL-2, phase 3 clinical trials assessing Q4W or Q8W subcutaneous  VRDN-003 in active and chronic TED, progressing as planned and on track for topline data for both trials in the first half of 2026 -. - Proof-of-concept IgG reduction clinical data in healthy volunteers anticipated in the third quarter of 2025 for VRDN-006, an Fc fragment inhibitor of the neonatal Fc receptor  -. \"Turning to our FcRn inhibitor portfolio, we anticipate proof-of-concept data in healthy volunteers, including IgG reduction, in Q3 2025. We also continue to advance our bispecific, half-life extended, potential best-in-class VRDN-008 prog","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/viridian-therapeutics-highlights-recent-progress-120000150.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B66KJ199.SGD","BK4215","BK4139","PRGS","VRDN","IE00B7SZL793.SGD","MG","MAA","BK4585","BK4588","BK4123","BK4097","IE00B19Z4B17.USD","LU2065732104.USD","LENZ","THAC","IE0031619046.USD"],"gpt_icon":0}],"pageSize":16,"totalPage":13,"pageCount":2,"totalSize":200}]}}